Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21. [electronic resource]
Producer: 20200330Description: G408-G428 p. digitalISSN:- 1522-1547
- Animals
- Antigens, CD -- biosynthesis
- Antigens, Differentiation, Myelomonocytic -- biosynthesis
- Cytokines -- metabolism
- Enzyme Inhibitors -- toxicity
- Hepatic Stellate Cells -- drug effects
- Kupffer Cells -- drug effects
- Liver Cirrhosis -- chemically induced
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- MicroRNAs -- genetics
- Microcystins -- toxicity
- NADPH Oxidase 2 -- genetics
- NADPH Oxidases -- metabolism
- Non-alcoholic Fatty Liver Disease -- chemically induced
- Peroxynitrous Acid -- metabolism
- Protein Phosphatase 2 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.